Group One Trading
INFI

Group One Trading’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Group One Trading’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,150
Closed -$2.98K – 8574
2023
Q2 		$2.98K Sell
14,150
-28,642
-67% -$4.97K ﹤0.01% 6940
2023
Q1 		$6.85K Sell
42,792
-45,263
-51% -$20.1K ﹤0.01% 6147
2022
Q4 		$48.9K Sell
88,055
-11,248
-11% -$9.57K ﹤0.01% 5013
2022
Q3 		$118K Buy
99,303
+23,000
+30% +$24.8K ﹤0.01% 4623
2022
Q2 		$48K Buy
76,303
+10,071
+15% +$7.73K ﹤0.01% 5597
2022
Q1 		$76K Sell
66,232
-32,355
-33% -$38.7K ﹤0.01% 5760
2021
Q4 		$222K Sell
98,587
-60,151
-38% -$151K ﹤0.01% 4976
2021
Q3 		$543K Buy
158,738
+129,219
+438% +$398K ﹤0.01% 4103
2021
Q2 		$88K Buy
+29,519
New +$93.4K ﹤0.01% 6090
2021
Q1 		– Sell
-27,156
Closed -$90.6K – 8169
2020
Q4 		$58K Sell
27,156
-4,638
-15% -$7.65K ﹤0.01% 4924
2020
Q3 		$37K Buy
31,794
+22,704
+250% +$23.3K ﹤0.01% 4832
2020
Q2 		$8K Hold
9,090
– – ﹤0.01% 5238
2020
Q1 		$8K Buy
+9,090
New +$10.5K ﹤0.01% 4652
2019
Q4 		– Sell
-1,619
Closed -$1.78K – 5775
2019
Q3 		$2K Sell
1,619
-1,126
-41% -$1.53K ﹤0.01% 4939
2019
Q2 		$5K Sell
2,745
-7,372
-73% -$11.9K ﹤0.01% 4619
2019
Q1 		$19K Buy
10,117
+411
+4% +$601 ﹤0.01% 4058
2018
Q4 		$11K Buy
9,706
+744
+8% +$1.34K ﹤0.01% 4250
2018
Q3 		$24K Sell
8,962
-6,038
-40% -$12.5K ﹤0.01% 4332
2018
Q2 		$29K Sell
15,000
-22,783
-60% -$46K ﹤0.01% 4228
2018
Q1 		$79K Buy
+37,783
New +$81K ﹤0.01% 3399
2017
Q4 		– Sell
-15,072
Closed -$31.3K – 5348
2017
Q3 		$20K Buy
+15,072
New +$18.7K ﹤0.01% 4072
2017
Q1 		– Sell
-23,009
Closed -$56.6K – 5114
2016
Q4 		$31K Buy
23,009
+7,705
+50% +$10.1K ﹤0.01% 3518
2016
Q3 		$24K Buy
15,304
+13,501
+749% +$20.7K ﹤0.01% 3719
2016
Q2 		$2K Buy
1,803
+1,800
+60,000% +$8.42K ﹤0.01% 4453
2016
Q1 		$0 Sell
3
-20,620
-100% -$126K ﹤0.01% 5064
2015
Q4 		$162K Sell
20,623
-5,144
-20% -$44.3K ﹤0.01% 2653
2015
Q3 		$218K Sell
25,767
-7,365
-22% -$67.9K ﹤0.01% 2445
2015
Q2 		$363K Buy
33,132
+9,840
+42% +$126K 0.01% 2058
2015
Q1 		$326K Buy
23,292
+295
+1% +$4.51K 0.01% 1963
2014
Q4 		$388K Buy
22,997
+16,269
+242% +$237K 0.01% 1756
2014
Q3 		$90K Sell
6,728
-18,311
-73% -$218K ﹤0.01% 3093
2014
Q2 		$319K Sell
25,039
-46,062
-65% -$480K ﹤0.01% 2003
2014
Q1 		$845K Sell
71,101
-148,792
-68% -$2M 0.01% 1215
2013
Q4 		$3.04M Buy
219,893
+165,968
+308% +$2.34M 0.05% 434
2013
Q3 		$941K Buy
53,925
+40,526
+302% +$776K 0.02% 1066
2013
Q2 		$218K Buy
+13,399
New +$415K 0.01% 2093

Other funds holding INFI

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Group One Trading's INFI Position: Q3 2023 in Review

Group One Trading sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 14,150 shares — an estimated $2.98K sold.

Group One Trading first reported a position in INFI in Q2 2013 and held it in 36 quarters. The position peaked at $3.04M in Q4 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Group One Trading reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 14,150 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $2.98K.
  • Group One Trading first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 36 quarters.
  • Group One Trading's Infinity Pharmaceuticals, Inc. position peaked at $3.04M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.